Enrico Gottardi

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden et al. · Leukemia · 2003 · 884 citations

Medicine, Molecular Biology, Oncology +16

Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

Daniela Cilloni, Aline Renneville, Fabienne Hermitte et al. · Journal of Clinical Oncology · 2009 · 434 citations · Full text

Medicine, Hematology, Oncology +17

Impact of Baseline <i>BCR-ABL</i> Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Timothy P. Hughes, Giuseppe Saglio, Susan Branford et al. · Journal of Clinical Oncology · 2009 · 309 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +14

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Paolo Gorello, Giovanni Cazzaniga, Federica Alberti et al. · Leukemia · 2006 · 299 citations

Medicine, Hematology, Oncology +15

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

Daniela Cilloni, Enrico Gottardi, Daniela De Micheli et al. · Leukemia · 2002 · 243 citations

Medicine, Hematology, Oncology +17